Spironolactone Treatment of Porphyria Cutanea Tarda-Associated Hirsutism

    Gillian Gibson, Gillian Murphy
    Studysummary This case report describes the effective use of spironolactone for hirsutism in a patient with porphyria cutanea tarda.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Oral Spironolactone Therapy for Female Patients with Acne, Hirsutism, or Androgenic Alopecia British Journal of Dermatology · 1985

    Related research 5

    1. Hirsutism PubMed · 2007
    2. Medical Treatment Regimens of Hirsutism Reproductive biomedicine online · 2004
    3. Anti-Androgens for the Treatment of Hirsutism Expert opinion on investigational drugs · 2002
    4. Management of Hirsutism American journal of clinical dermatology · 2000
    5. Spironolactone Treatment of Porphyria Cutanea Tarda-Associated Hirsutism Journal of Dermatological Treatment · 1994